TrialBritish journal of clinical pharmacology2017

Tolerability, pharmacokinetics and antiviral activity of rHSA/IFNα2a for the treatment of chronic hepatitis B infection.

Yanhua Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.